✦ LIBER ✦

383Toxicity following preoperative combined modality therapy in cancers of the oral cavity and oropharynx

✍ Scribed by W. Dobrowsky; W. Millesi; G. Tatzreiter; B. Pokrajac; C. Glaser; E. Dobrowsky

Book ID: 119521618
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 118 KB
Volume: 40
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(96)80392-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined modality treatment of advanced

Combined modality treatment of advanced cancers of the oral cavity and oropharynx

✍ W. Dobrowsky; E. Dobrowsky; H. Strassl; O. Braun; N. Gritzmann; V. Schemer 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 477 KB

Second head and neck cancers following r

Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx

✍ Jacek Fijuth; Jean-Jacques Mazeron; Cécile Le Péchoux; Pascal Piedbois; Michel M 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 667 KB

Intra-arterial methotrexate chemotherapy

Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx

✍ J. M. Richard; H. Sancho; Y. Lepintre; J. Rodary; B. Pierquin 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 2 views

Survival evaluation of treatment modalit

Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx

✍ Josep Pericot; Josep M. Escribà; Andrés Valdés; Marı́a J. Biosca; Antoni Monner; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Preoperative induction chemotherapy foll

Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx : A phase II study

✍ Jordi L. Giralt; Javier Gonzalez; Josep M. del Campo; Javier Maldonado; Xavier S 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## BACKGROUND. Combined modality therapy plays a central role in the management of advanced head and neck tumors. The objective of our Phase II study was to determine the feasibility, toxicity, and clinical and pathologic response of preoperative induction chemotherapy, followed by concurrent chem

Preoperative concurrent paclitaxel, carb

Preoperative concurrent paclitaxel, carboplatin and radiotherapy in advanced operable cancer of the oropharynx and oral cavity: a phase II evaluation

✍ A. Eckhardt; I. Wildfang; J.H. Karstens 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 138 KB